Hologic Recalls BioZorb 3D Markers Due to Patient Complications Risk

The FDA posted on its website that Hologic recalled its BioZorb 3D Bioabsorbable Markers due to risk for patient complications. The use of "affected product may cause serious adverse health consequences, including pain, infection, rash, device moving from where it was placed (migration), device breaking through the skin (erosion), fluid buildup under the skin (seroma), other complications and/or additional medical treatments, and death," the agency said. There have been 252 reported injuries with o reports of death.